Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI

BACKGROUND: Ferumoxytol is approved for use in the treatment of iron deficiency anemia, but it can serve as an alternative to gadolinium-based contrast agents. On the basis of postmarketing surveillance data, the Food and Drug Administration issued a black box warning regarding the risks of rare but...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiology
Main Authors: Nguyen, Kim-Lien, Yoshida, Takegawa, Kathuria-Prakash, Nikhita, Zaki, Islam H., Varallyay, Csanad G., Semple, Scott I., Saouaf, Rola, Rigsby, Cynthia K., Stoumpos, Sokratis, Whitehead, Kevin K., Griffin, Lindsay M., Saloner, David, Hope, Michael D., Prince, Martin R., Fogel, Mark A., Schiebler, Mark L., Roditi, Giles H., Radjenovic, Aleksandra, Newby, David E., Neuwelt, Edward A., Bashir, Mustafa R., Hu, Peng, Finn, J. Paul
Formato: Artigo
Idioma:Inglês
Publicado em: Radiological Society of North America 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6884068/
https://ncbi.nlm.nih.gov/pubmed/31638489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1148/radiol.2019190477
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados